203 related articles for article (PubMed ID: 10980924)
1. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
Bonkovsky HL; Obando JV
Curr Gastroenterol Rep; 1999; 1(1):30-7. PubMed ID: 10980924
[TBL] [Abstract][Full Text] [Related]
2. Iron as a co-morbid factor in nonhemochromatotic liver disease.
Bonkovsky HL; Lambrecht RW; Shan Y
Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
[TBL] [Abstract][Full Text] [Related]
3. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
5. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
6. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
7. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
Press RD; Flora K; Gross C; Rabkin JM; Corless CL
Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
[TBL] [Abstract][Full Text] [Related]
8. Iron and liver diseases.
Fargion S; Mattioli M; Fracanzani AL; Fiorelli G
Can J Gastroenterol; 2000 Nov; 14 Suppl D():89D-92D. PubMed ID: 11110619
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
13. HFE gene in primary and secondary hepatic iron overload.
Sebastiani G; Walker AP
World J Gastroenterol; 2007 Sep; 13(35):4673-89. PubMed ID: 17729389
[TBL] [Abstract][Full Text] [Related]
14. [Iron in the era of molecular biology].
Deugnier Y; Moirand R; Brissot P; David V
Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
[TBL] [Abstract][Full Text] [Related]
15. [Genetic hemochromatosis and the HFE gene: from molecular genetics to clinical diagnosis].
Höhler T; Gerken G
Z Gastroenterol; 2000 Jun; 38(6):509-15. PubMed ID: 10923364
[TBL] [Abstract][Full Text] [Related]
16. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
17. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
[TBL] [Abstract][Full Text] [Related]
19. Iron in nonhemochromatotic liver disorders.
Alla V; Bonkovsky HL
Semin Liver Dis; 2005 Nov; 25(4):461-72. PubMed ID: 16315139
[TBL] [Abstract][Full Text] [Related]
20. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]